FindTrial
Sign In

Quality assessment of report in clinical biochemistry laboratory using Sigma scale.

Developing hazard ratio & risk priority number for test method performance- A risk management study in clinical biochemistry laboratory

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/02/007756
Enrollment
100
Registered
2017-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Control Intervention1: NIL: NIL

Sponsors

Father Muller Medical College institutional grants committee
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: CV% and %BIAS derived from the IQC (internal Quality control) and EQAS (external Quality Assurance Program) report was used to assess the test method performance in clinical biochemistry.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The Risk to the Patient with the error in test method performance in clinical biochemistry.Timepoint: followed every Month for 1 year—

Secondary

MeasureTime frame
The risk reduction in the error in report after the specific corrective action has been implemented in the test method performanceTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Avinash S S

Father Muller Medical College Hospital.

dravinash.ss@gmail.com09844612833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026